MEDICATION THERAPY MANAGEMENT AND
PATIENT-CENTERED CARE GUIDE
COMPREHENSIVE TEST SCRIPT 2026
SOLUTIONS VERIFIED
◉ MTM Process Steps. Answer: 1. Comprehensive MTR plus targeted
reviews as necessary; 2. Collaborative creation and updating of PMR
and MAP; 3. Direct interventions and referrals, as indicated.
◉ Systematic identification of DTPs. Answer: The process of
identifying DTPs through a comprehensive review of patient clinical
data, drug charts, medical records, laboratory tests, and direct
patient or caregiver interviews.
◉ Cipolle's classification. Answer: A structured tool used by clinical
pharmacists to systematically evaluate medication regimens for
possible issues in indication, effectiveness, safety, and adherence.
◉ Optimal therapeutic goals. Answer: The desired outcomes of drug
therapy that DTPs hinder the achievement of.
◉ Clinical intervention. Answer: Actions taken to resolve DTPs and
improve patient care.
, ◉ Comprehensive review. Answer: An extensive evaluation of
various patient-related data sources to identify DTPs.
◉ Patient clinical data. Answer: Information related to a patient's
health status and treatment history used in the identification of
DTPs.
◉ Medication regimens. Answer: The prescribed plan for
administering medications to a patient, which may be evaluated for
DTPs.
◉ Direct patient or caregiver interviews. Answer: Conversations
with patients or their caregivers to gather information relevant to
identifying DTPs.
◉ Structured tools. Answer: Frameworks or methodologies used by
clinical pharmacists to systematically assess medication-related
issues.
◉ Unnecessary drug therapy. Answer: Drug given without a valid
medical reason, duplication of therapy, or continuation after
indication has resolved.
PATIENT-CENTERED CARE GUIDE
COMPREHENSIVE TEST SCRIPT 2026
SOLUTIONS VERIFIED
◉ MTM Process Steps. Answer: 1. Comprehensive MTR plus targeted
reviews as necessary; 2. Collaborative creation and updating of PMR
and MAP; 3. Direct interventions and referrals, as indicated.
◉ Systematic identification of DTPs. Answer: The process of
identifying DTPs through a comprehensive review of patient clinical
data, drug charts, medical records, laboratory tests, and direct
patient or caregiver interviews.
◉ Cipolle's classification. Answer: A structured tool used by clinical
pharmacists to systematically evaluate medication regimens for
possible issues in indication, effectiveness, safety, and adherence.
◉ Optimal therapeutic goals. Answer: The desired outcomes of drug
therapy that DTPs hinder the achievement of.
◉ Clinical intervention. Answer: Actions taken to resolve DTPs and
improve patient care.
, ◉ Comprehensive review. Answer: An extensive evaluation of
various patient-related data sources to identify DTPs.
◉ Patient clinical data. Answer: Information related to a patient's
health status and treatment history used in the identification of
DTPs.
◉ Medication regimens. Answer: The prescribed plan for
administering medications to a patient, which may be evaluated for
DTPs.
◉ Direct patient or caregiver interviews. Answer: Conversations
with patients or their caregivers to gather information relevant to
identifying DTPs.
◉ Structured tools. Answer: Frameworks or methodologies used by
clinical pharmacists to systematically assess medication-related
issues.
◉ Unnecessary drug therapy. Answer: Drug given without a valid
medical reason, duplication of therapy, or continuation after
indication has resolved.
